glp 1 tirzepatida Eli Lilly to seek approval of new GLP-1 weight-loss drug this year Tirzepatide, a dual GIP/GLP-1 receptor
Pay in 4 interest-free payments of $5.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17






























